BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 37409717)

  • 21. Long-term results of teduglutide treatment for chronic intestinal failure - Insights from a national, multi-centric patient home-care service program.
    Greif S; Maasberg S; Wehkamp J; Fusco S; Zopf Y; Herrmann HJ; Lamprecht G; Jacob T; Schiefke I; von Websky MW; Büttner J; Blüthner E; Tacke F; Pape UF
    Clin Nutr ESPEN; 2022 Oct; 51():222-230. PubMed ID: 36184208
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety and Efficacy of Teduglutide (Gattex) in Patients With Crohn's Disease and Need for Parenteral Support Due to Short Bowel Syndrome-associated Intestinal Failure.
    Kochar B; Long MD; Shelton E; Young L; Farraye FA; Yajnik V; Herfarth H
    J Clin Gastroenterol; 2017 Jul; 51(6):508-511. PubMed ID: 27433811
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Randomised placebo-controlled trial of teduglutide in reducing parenteral nutrition and/or intravenous fluid requirements in patients with short bowel syndrome.
    Jeppesen PB; Gilroy R; Pertkiewicz M; Allard JP; Messing B; O'Keefe SJ
    Gut; 2011 Jul; 60(7):902-14. PubMed ID: 21317170
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Experience With Teduglutide in Pediatric Short Bowel Syndrome: First Real-life Data.
    Ramos Boluda E; Redecillas Ferreiro S; Manrique Moral O; García Romero R; Irastorza Terradillos I; Nuñez Ramos R; Germán Díaz M; Polo Miquel B; Vives Piñera I; Alcolea Sánchez A; González Sacristán R; Bautista Barea M; Moreno Villares JM
    J Pediatr Gastroenterol Nutr; 2020 Dec; 71(6):734-739. PubMed ID: 32804906
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Teduglutide for pediatric short bowel syndrome patients.
    Rosete BE; Wendel D; Horslen SP
    Expert Rev Gastroenterol Hepatol; 2021 Jul; 15(7):727-733. PubMed ID: 33798402
    [No Abstract]   [Full Text] [Related]  

  • 26. Teduglutide for treatment of adult patients with short bowel syndrome.
    Billiauws L; Bataille J; Boehm V; Corcos O; Joly F
    Expert Opin Biol Ther; 2017 May; 17(5):623-632. PubMed ID: 28293969
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Teduglutide enhances structural adaptation of the small intestinal mucosa in patients with short bowel syndrome.
    Tappenden KA; Edelman J; Joelsson B
    J Clin Gastroenterol; 2013 Aug; 47(7):602-7. PubMed ID: 23426461
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Teduglutide reduces need for parenteral support among patients with short bowel syndrome with intestinal failure.
    Jeppesen PB; Pertkiewicz M; Messing B; Iyer K; Seidner DL; O'keefe SJ; Forbes A; Heinze H; Joelsson B
    Gastroenterology; 2012 Dec; 143(6):1473-1481.e3. PubMed ID: 22982184
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Quality of Life in Teduglutide-Treated Patients with Short Bowel Syndrome Intestinal Failure-A Nested Matched Pair Real-World Study.
    Blüthner E; Pape UF; Tacke F; Greif S
    Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111167
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The Impact of Teduglutide on Real-Life Health Care Costs in Children with Short Bowel Syndrome.
    Cucinotta U; Acunzo M; Payen E; Talbotec C; Chasport C; Alibrandi A; Lacaille F; Lambe C
    J Pediatr; 2023 Dec; 272():113882. PubMed ID: 38135030
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Teduglutide, a glucagon-like peptide-2 analog for the treatment of gastrointestinal diseases, including short bowel syndrome.
    Yazbeck R
    Curr Opin Mol Ther; 2010 Dec; 12(6):798-809. PubMed ID: 21154171
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Citrulline correlations in short bowel syndrome-intestinal failure by patient stratification: Analysis of 24 weeks of teduglutide treatment from a randomized controlled study.
    Jeppesen PB; Gabe SM; Seidner DL; Lee HM; Olivier C
    Clin Nutr; 2020 Aug; 39(8):2479-2486. PubMed ID: 31784300
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of adult short bowel syndrome patients with teduglutide.
    Nørholk LM; Holst JJ; Jeppesen PB
    Expert Opin Pharmacother; 2012 Feb; 13(2):235-43. PubMed ID: 22224470
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The Variable Response to Teduglutide in Pediatric Short Bowel Syndrome: A Single Country Real-Life Experience.
    Guz-Mark A; Hino B; Berkowitz D; Hartman C; Millman PN; Orlanski-Meyer E; Shaoul R; Spector-Cohen I; Weiss B; Zangen T; Shamir R
    J Pediatr Gastroenterol Nutr; 2022 Sep; 75(3):293-298. PubMed ID: 35730756
    [TBL] [Abstract][Full Text] [Related]  

  • 35. New approaches to the treatments of short bowel syndrome-associated intestinal failure.
    Jeppesen PB
    Curr Opin Gastroenterol; 2014 Mar; 30(2):182-8. PubMed ID: 24406477
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Reduction of Parenteral Nutrition and Hydration Support and Safety With Long-Term Teduglutide Treatment in Patients With Short Bowel Syndrome-Associated Intestinal Failure: STEPS-3 Study.
    Seidner DL; Fujioka K; Boullata JI; Iyer K; Lee HM; Ziegler TR
    Nutr Clin Pract; 2018 Aug; 33(4):520-527. PubMed ID: 29761915
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical Management of Patients With Parenteral Nutrition-Dependent Short Bowel Syndrome During Teduglutide Therapy.
    Compher C; Boullata JI; Pickett-Blakely O; Schiavone P; Stoner N; Kinosian BP
    JPEN J Parenter Enteral Nutr; 2016 Nov; 40(8):1183-1190. PubMed ID: 26111832
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Efficacy of Teduglutide for Parenteral Support Reduction in Patients with Short Bowel Syndrome: A Systematic Review and Meta-Analysis.
    Bioletto F; D'Eusebio C; Merlo FD; Aimasso U; Ossola M; Pellegrini M; Ponzo V; Chiarotto A; De Francesco A; Ghigo E; Bo S
    Nutrients; 2022 Feb; 14(4):. PubMed ID: 35215445
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glucagon-like peptide 2 analogues in the treatment of intestinal failure: A qualitative exploration of the views of patients and their families in decision making.
    Sowerbutts AM; Burden S; Griffiths J; Abraham A; Farrer K; Leahy G; Teubner A; Cloutier A; Twist K; Kelly S; Lal S
    Clin Nutr ESPEN; 2021 Aug; 44():263-269. PubMed ID: 34330477
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term Outcomes With Teduglutide From a Single Center.
    Puello F; Wall E; Herlitz J; Lozano ES; Semrad C; Micic D
    JPEN J Parenter Enteral Nutr; 2021 Feb; 45(2):318-322. PubMed ID: 32391948
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.